国际皮肤性病学杂志    2004 30 (3): 176-178   ISSN: 2096-5540  CN: 32-1880/R   皮肤鳞状细胞癌和基底细胞癌基质金属蛋白酶表达及其与肿瘤转移的关系 马泽粦, 樊翌明 广东医学院附属医院皮肤科 湛江 524001 收稿日期 2003-07-04  修回日期 null  网络版发布日期 null 参考文献  [1] Wagner SN, Ockenfels HM, Wagner C, et al. Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas. J Invest Derrnatol, 1996, 106:321-326. [2] Dumas V, Kanitakis J, Charvat S, et al. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Antieancer Res, 1999, 19(4 B) :2929-2938. [3] O-Charoenrat P, Rhys-Evans PH, Eceles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 2001, 127:813-820. [4] Airola K, Fusenig NE. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J Invest Dermatol,2001, 116:85-92. [5] Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.Hum Pathol, 2000, 31:895-904. [6] Airola K, Johansson N, Kariniemi AL, et al. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol, 1997, 109:225-231. [7] Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and-2) activities by transforming growth factor-betal in human prostate cancer cell lines. Mol Biol Cell, 1999,10:407-416. [8] Johansson N, Airola K, Grenman R, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol, 1997, 151:499-508. [9] Kerkela E, Ala-aho R, Lohi J,et al. Differential patterns of stromelysin-2 (MMP-10) and MTl-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer, 2001, 84:659-669. [10] Kerkela E, Ala-Aho R, Jeskanen L, et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol, 2000, 114:1113-1119. [11] Yoshizaki T, Maruyama Y, Sato H, et al. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Iht J Cancer, 2001,95:44-50. [12] Tsukifuji R, Tagawa K, Hatamochi A, et al. Expression of matrix metalloproteinase-1,-2 and-3 in squamous cell carcinoma and actinic keratosis. Br J Cancer, 1999, 80:1087-1091. [13] Varani J, Hattori Y, Chi Y, et al. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin. Br J Cancer, 2000, 82:657-665. [14] Tsukifuji R, Sakai Y, Hatamochi A, et al. Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase. Histochem J, 1997, 29:401-407. [15] Majmudar G, Nelson BR, Jensen TC, et al. Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinog, 1994, 9:17-23. [16] Wagner SN, Ruhri C, Kunth K, et al. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma. Diagn Mol Pathol, 1992, 1:200-205. [17] Thewes M, Worret WI, Engst R, et al. Stromelysin-3 (ST-3):immunohistochemical characterization of the matrix metalloproteinase(MMP)-11 in benign and malignant skin tumours and other skin disorders. Clin Exp Dermatol. 1999. 24:122-126. 通讯作者: